vimarsana.com

Page 294 - பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா இல் தேவாலயம் மலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Best of the Small Presses 2022

Best of the Small Presses 2022 Two stories from the New England Review have been selected for inclusion in the next Pushcart Prize collection: McKenna Marsden’s “Suffering in Motion” ( NER 40.4) and Lindsay Starck’s “Baikal” ( NER 41.4). The XLVI edition will be published in November 2021. McKenna Marsden, a current MFA candidate at the University of Maryland-College Park, grew up in Oregon and spent the majority of their adult life in greater Boston. “Suffering in Motion” was their first publication. Marsden talks to  NER staff reader  Laur Freymiller about “Suffering in Motion” in our Behind the Byline feature. The story is also read aloud by

FSU eyes candidates to replace Thrasher as president

FSU eyes candidates to replace Thrasher as president Members of public express opposition to Corcoran’s bid Published:  Tags:  FSU President John Thrasher (Florida State University photo) TALLAHASSEE, Fla. – As Florida State University seeks a successor to retiring President John Thrasher, a committee Friday started interviewing nine finalists for the job as questions swirled about a potential conflict of interest for one high-profile candidate and as a student campaign emerged for another. The university’s Presidential Search Advisory Committee began a two-day process of interviewing the finalists, a mix of politically connected local candidates and academics from universities throughout the country.

Creating a narrative and promoting it for a political agenda

This is how everyone savvy is doing it, yes ALL SIDES now, not just alt-right. It s our new paradigm. How MSM outlets deal with it, whether they filter it and create balance, or end up feeding certain agendas by covering what the aglorithms rule are hot, that s the thing: “Focus on conflict. Feed the algorithm. Make sure whatever you produce reinforces a narrative. Don’t worry if it is true.” https://t.co/9boLCcUyzH Omar Wasow (@owasow) April 16, 2021

Pediatricians are gearing up to vaccinate the nation s youths

Pediatricians are gearing up to vaccinate the nation s youths Erika Edwards © Provided by NBC News Now that both the Food and Drug Administration and the Centers for Disease Control and Prevention have green-lighted Pfizer s Covid-19 vaccine for emergency use in kids ages 12 to 15, pediatricians will soon find themselves on the front lines of the country s vaccination efforts, playing an essential role in communicating to parents the safety and importance of getting their kids the shot. That s a tall order for pediatricians who say they re facing skyrocketing vaccine hesitancy among families. It s not like I can just send out a big message that says, Everybody get your flu shot! said Dr. Natasha Burgert, a pediatrician in Overland Park, Kansas, and a national spokesperson for the American Academy of Pediatrics. It s hard, especially for those of us who are communicating with these families every day.

NC Biotechnology Center awards $1 8M in grants, loans – here s the breakdown

by Barry Teater, NCBiotech Writer May 13, 2021 . RESEARCH TRIANGLE PARK  The North Carolina Biotechnology Center awarded 48 grants and loans totaling nearly $1.8 million to universities, bioscience companies and other entities in the third quarter of its fiscal year. The awards, made in January, February and March, support life sciences research, technology commercialization and entrepreneurship throughout North Carolina. The funding also helps universities and companies attract follow-on funding from other sources. Company loans Three bioscience companies received Small Business Research Loans totaling $550,000 to advance their research, product development and commercial viability. Alacrity Medical Innovations of Chapel Hill received $100,000 to complete prototype development and prepare for an Investigational New Drug (IND) filing with the U.S. Food and Drug Administration for a disposable, drug-device combination product that treats mild to moderate bleeding in patients

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.